We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Ultrasensitive Droplet Biosensing Method Dramatically Shortens Identification Time for COVID-19

By LabMedica International staff writers
Posted on 30 Jul 2020
Print article
Image: Ultrasensitive Droplet Biosensing Method Dramatically Shortens Identification Time for COVID-19 (Photo courtesy of Virginia Tech)
Image: Ultrasensitive Droplet Biosensing Method Dramatically Shortens Identification Time for COVID-19 (Photo courtesy of Virginia Tech)
Scientists at Virginia Tech (Blacksburg, VA) have developed an ultrasensitive biosensing method that could dramatically shorten the amount of time required to verify the presence of the COVID-19 virus in a sample.

Currently, there is significant room to improve the pace of coronavirus testing. COVID-19 verification tests require a few hours to complete, as verification of the presence of the virus requires the extraction and comparison of viral genetic material, a time-intensive process requiring a series of steps. The amount of virus in a sampling is also subject to error, and patients who have had the virus for a shorter period of time may test negative because there is not enough of the virus present to trigger a positive result.

The Virginia Tech scientists have developed a method in which all the contents of a sampling droplet can be detected, and there is no extraction or other tedious procedures. The contents of a microdroplet are condensed and characterized in minutes, drastically reducing the error margin and giving a clear picture of the materials present. The key to this method is in creating a surface over which water containing the sample travels in different ways. On surfaces where drops of water may “stick” or “glide,” the determining factor is friction. Surfaces that introduce more friction cause water droplets to stop, whereas less friction causes water droplets to glide over the surface uninhibited.

The method starts by placing a collected sample into liquid. The liquid is then introduced into an engineered substrate surface with both high and low friction regions. Droplets containing sample will move more quickly in some areas but anchor in other locations thanks to a nanoantenna coating that introduces more friction. These stop-and-go waterslides allow water droplets to be directed and transported in a programmable and reconfigurable fashion. The “stopped” locations are very small because of an intricately placed coating of carbon nanotubes on etched micropillars.

These prescribed spots with nanoantennae are established as active sensors. The substrate surface is then heated so that the anchored water droplet starts to evaporate. In comparison with natural evaporation, this so-called partial Leidenfrost-assisted evaporation provides a levitating force which causes the contents of the droplet to float toward the nanoantenna as the liquid evaporates. The bundle of sample particles shrinks toward the constrained center of the droplet base, resulting in a rapidly-produced package of analyte molecules. For fast sensing and analysis of these molecules, a laser beam is directed onto the spot with the packed-in molecules to generate their vibrational fingerprint light signals, a description of the molecules expressed in waveforms. All of this happens in just a few minutes, and the fingerprint spectrum and frequency of the coronavirus can be quickly picked out of a lineup of the returned data. The Virginia Tech scientists are now pursuing a patent on the method, and are also pursuing funding from the National Institutes for Health to deliver the method for widespread use.

Related Links:
Virginia Tech

Gold Member
Universal Transport Solution
Puritan®UniTranz-RT
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Anti-HHV-6 IgM Assay
anti-HHV-6 IgM ELISA (semiquant.)
New
HIV-1 Test
HIV-1 Real Time RT-PCR Kit

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.